Magnolol Pretreatment Prevents from Sepsis-induced Intestinal Dysmotility by Corrective Oxidative

苗彬,张淑文,王红,齐文杰,王超,胡岚,黄光伟
DOI: https://doi.org/10.3969/j.issn.1007-6948.2015.04.010
2015-01-01
Abstract:Objective To investigate the mechanism by which magnolol treatment prevents from sepsis-in?duced dysmotility in LPS-treated mice and role of oxidative stress. Methods Sepsis was induced by intrave?nous tail vein injection of LPS. Sixty mice were divided into four groups: the magnolol-treated septic group, the mosapride-treated septic group,the placebo-treated septic group, and the placebo-treated sham-operated group. Intestinal transit and circular smooth muscle contraction were measured 12 h after LPS injection, and the mRNA levels of iNOS were determined by RT-PCR. NO content, superoxide dismutase (SOD) activity, and malondialde?hyde (MDA) concentration were detected using commercial kits. Results Intestinal transit and muscular con?tractility were significantly lower in the LPS-treated group than in the control group. In LPS-treated animals, magnolol pretreatment significantly accelerated intestinal transit (P<0.05), increased circular muscle contrac?tion (P<0.05). In addition, NO concentration and iNOS expression were significantly increased in the LPS-treated group compared with the control group (P<0.05). Furthermore, SOD activity was significantly re?duced and MDA concentration was significantly increased in the LPS-treated group compared with the control group (P<0.05). Magnolol pretreatment prevented the sepsis-induced increase in NO concentration, iN?OS expression, and MDA concentration, and de?crease in SOD activity in LPS-treated animals (P<0.05). Conclusion The laboratory results suggest?ed that magnolol treatment can prevent from sep?sis-induced intestinal dysmotility by regulating oxidative stress.
What problem does this paper attempt to address?